Amalia Muñoz

Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework

D. Greco, Laure-Alix Clerbaux, M. C. Albertini, 2022, Journal of clinical medicine.

Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways

Laure-Alix Clerbaux, M. Amorim, S. Coecke, 2022, Journal of clinical medicine.

Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19

Laure-Alix Clerbaux, N. Lanthier, M. C. Albertini, 2022, Journal of clinical medicine.

Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework

Laure-Alix Clerbaux, K. Kanninen, S. Coecke, 2022, Cells.

The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19

Laure-Alix Clerbaux, H. Hogberg, F. Pistollato, 2022, Cells.

Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development

S. Cristoni, Laure-Alix Clerbaux, R. Sanges, 2022, Reproductive Toxicology.

COVID-19 through Adverse Outcome Pathways: Building Networks to Better Understand the Disease – 3rd CIAO AOP Design Workshop

Young Jun Kim, Holly M. Mortensen, M. Vinken, 2022, ALTEX.